FDA approves Novartis hypertension drug
(AP)


AP - Swiss pharmaceutical maker Novartis AG said Tuesday it has received U.S. approval for the hypertension drug Tekturna — a potential blockbuster that has shown the ability to lower blood pressure more effectively than common treatments.